RecruitingNCT02634645

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium


Sponsor

University of Colorado, Denver

Enrollment

5,000 participants

Start Date

Jan 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two ways to treat Barrett's esophagus with early-stage cancer: (1) surgery to remove part of the esophagus, or (2) a combination of endoscopic procedures (non-surgical treatments done with a camera through the mouth) to remove the abnormal tissue. **You may be eligible if...** - You have Barrett's esophagus (a condition where the lining of the esophagus changes) with early-stage cancer or pre-cancerous changes - Your cancer is confined to the top layers of the esophagus and has not spread deeper or to lymph nodes - You are healthy enough to undergo either surgery or endoscopic treatment - Your doctor has confirmed through imaging and tissue sampling that you meet the criteria **You may NOT be eligible if...** - Your cancer has grown deeper into the esophagus wall or spread to lymph nodes - You have had previous treatment for this condition - You have other serious health conditions that make either procedure unsafe - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic eradication therapies (EET)

Endoscopic eradication therapies (EET) includes endoscopic mucosal resection (EMR), which describes the process by which the area most likely to harbor highest grade of dysplasia/neoplasia is removed; radiofrequency ablation (RFA), which describes the process by which Barrett's segments are removed via burning/ablation; and cryotherapy.

PROCEDUREEsophagectomy

The esophagus is surgically removed

DRUGChemotherapy

Chemical substances are used to treat cancer

RADIATIONRadiation

Cancer cells are destroyed by radiation therapy.


Locations(4)

UCLA Medical Center

Los Angeles, California, United States

Moffitt Cancer Center

Tampa, Florida, United States

Northwestern Memorial Hospital

Chicago, Illinois, United States

Washington University

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02634645


Related Trials